LogicBio Therapeutics, Inc

(NASDAQ:LOGC)

Latest On LogicBio Therapeutics, Inc (LOGC):

Date/Time Type Description Signal Details
2022-11-16 14:25 ESTNewsAstraZeneca's Alexion completes acquisition of genomic medicine company LogicBioN/A
2022-11-14 11:21 ESTNewsLogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72MN/A
2022-10-03 13:25 ESTNewsLogicBio jumps 648% on buyout deal with AstraZeneca unit AlexionN/A
2022-08-15 18:03 ESTNewsLogicBio GAAP EPS of -$0.15, revenue of $3.2MN/A
2022-05-24 22:23 ESTNewsLogicBio Therapeutics (LOGC) Investor Presentation - SlideshowN/A
2022-05-16 14:46 ESTNewsLogicBio GAAP EPS of -$0.20, revenue of $2.81MN/A
2022-05-09 12:48 ESTNewsLogicBio surges as FDA lifts clinical hold on lead assetN/A
2022-03-05 01:32 ESTNewsLogicBio GAAP EPS of -$1.24 beats by $0.08, revenue of $5.41M beats by $0.56MN/A
2022-02-04 06:43 ESTNewsLogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical holdN/A
2022-02-02 21:14 ESTNewsLogicBio falls on FDA clinical hold on gene therapy program for metabolic diseaseN/A
2021-11-22 05:25 ESTNewsWarning: LOGC is at high risk of performing badlyN/A
2021-08-09 10:42 ESTNewsLogicBio EPS misses by $0.14, misses on revenueN/A
2021-07-21 14:47 ESTNewsLogicBio trades higher as gene editing stocks rallyN/A
2021-04-27 20:08 ESTNewsLogicBio announces agreements with CANbridge Pharma and Daiichi SankyoN/A
2021-03-17 13:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 03:33 ESTNewsLogicBio EPS misses by $0.03, beats on revenueN/A
2021-03-16 21:18 ESTEarnings EstimateAn EPS average of -$1.44 is estimated for the 2022 year.Sell
2021-03-16 21:18 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-05 15:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.33 to $20.25.Neutral
2021-01-07 13:46 ESTNewsLogicBio extends collaboration with Children's Medical Research InstituteN/A
2021-01-06 16:04 ESTFinancialsCompany financials have been released.Neutral
2020-12-22 22:33 ESTNewsLogicBio Therapeutics names new CFON/A
2020-11-26 20:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 13:08 ESTNewsLooking In On LogicBioN/A
2020-11-12 12:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 12:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 04:21 ESTAnalyst RatingThe Analyst Target Price has decreased from $22 to $21.33.Neutral
2020-11-10 04:21 ESTEarnings EstimateAn EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-09 13:15 ESTNewsLogicBio reports Q3 resultsN/A
2020-11-07 16:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 08:43 ESTNewsLogicBio's LB-001 Fast Track'd for methylmalonic acidemia; shares +10%N/A
2020-11-05 08:43 ESTNewsLogicBio's LB-001 fast track'd in U.S. for an inherited metabolic disorderN/A
2020-11-04 05:37 ESTNewsLogicBio Therapeutics announces executive leadership changesN/A
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 296,296 shares.Buy
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 639,212 shares.Buy
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 545,974 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 296,296 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 639,212 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 545,974 shares.Buy
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 273,584 shares.Sell
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 174,219 shares.Sell
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 38,514 shares.Sell
2020-10-01 17:12 ESTNewsLogicBio readies equity offeringN/A
2020-10-01 17:10 ESTNewsLogicBio Therapeutics -30% on pricing of equity offeringN/A
2020-09-26 13:17 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 05:12 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 21:15 ESTAnalyst RatingThe Analyst Target Price has increased from $20.33 to $22.Buy
2020-08-11 05:05 ESTFinancialsCompany financials have been released.Neutral

About LogicBio Therapeutics, Inc (LOGC):

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. It has a partnership with Children's Medical Research Institute to develop new viral vectors; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop new genome editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company was founded in 2014 and is headquartered in Lexington, Massachusetts.

LOGC Quotes by TradingView

See Advanced Chart

General

  • Name LogicBio Therapeutics, Inc
  • Symbol LOGC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • IPO Date2018-10-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.logicbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 61.91
  • Price/Book (Most Recent Quarter) 4.4
  • Enterprise Value Revenue 62.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.16
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.35
  • Operating Margin -912%
  • Return on Assets -29%
  • Return on Equity -63%
  • Revenue 3.45 million
  • Earnings Per Share -$1.55
  • Revenue Per Share $0.14
  • Gross Profit 3.45 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 254.61 million
  • EBITDA -30350000
  • PE Ratio -0.64
  • Analyst Target Price $20.25
  • Book Value Per Share $1.93
View More

Share Statistics

  • Shares Outstanding 31.79 million
  • Shares Float 17.29 million
  • % Held by Insiders 1369%
  • % Held by Institutions 53%
  • Shares Short 827300
  • Shares Short Prior Month 677650
  • Short Ratio 6.35
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.31
  • 52 Week High $10
  • 52 Week Low $4.02
  • 50 Day Moving Average 8.36
  • 200 Day Moving Average 7.32
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

LogicBio Therapeutics, Inc (LOGC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

LogicBio Therapeutics, Inc (LOGC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.22-$0.3231.25%
2020-09-302020-11-09$N/A-$0.34-$0.4117.58%
2020-06-302020-08-10$N/A-$0.35-$0.4827.08%
2020-03-312020-05-11$1.02 million-$0.41-$0.4814.23%
2019-12-312020-03-16$N/A-$0.51-$0.49-5.15%
2019-09-302019-11-12$N/A-$0.48-$0.47-3.23%
2019-06-302019-08-13$N/A-$0.45-$0.40-12.5%
2019-03-312019-05-14$N/A-$0.34-$0.29-18.26%
2018-12-312018-12-31$N/A-$0.41-$0.39-5.13%
2018-09-302018-12-03$N/A-$4.03-$3.87-4.27%

LogicBio Therapeutics, Inc (LOGC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

LogicBio Therapeutics, Inc (LOGC) Chart:

LogicBio Therapeutics, Inc (LOGC) News:

Below you will find a list of latest news for LogicBio Therapeutics, Inc (LOGC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

LogicBio Therapeutics, Inc (LOGC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-1810CALL0 0553.14TRUE00
2025-07-1820CALL0 0341.67TRUE00
2025-07-1830CALL0 0488.2TRUE00
2025-07-1840CALL0 0558.96TRUE00
2025-07-1851.9CALL0 1299605.74TRUE00
2025-07-1860CALL0 413640.42TRUE00
2025-07-1870.65CALL0 284380.53TRUE00
2025-07-1880.3CALL0 524386.22FALSE00
2025-07-1890.3CALL0 156233.73FALSE00
2025-07-18100.2CALL0 100725.86FALSE00
2025-07-18110.2CALL0 1740.35FALSE00
2025-07-18120CALL0 0753.26FALSE00
2025-07-18130CALL0 0764.88FALSE00
2025-07-18140CALL0 0775.43FALSE00
2025-07-18150CALL0 9785.09FALSE00
2025-07-18160CALL0 0793.99FALSE00
2025-07-18170CALL0 0802.23FALSE00
2025-07-18180CALL0 0809.89FALSE00
2025-07-1810PUT0 00FALSE00
2025-07-1820PUT0 00FALSE00
2025-07-1830PUT0 00FALSE00
2025-07-1840PUT0 00FALSE00
2025-07-1850PUT0 00FALSE00
2025-07-1860.25PUT0 197820.11FALSE00
2025-07-1870.45PUT0 838629.89FALSE00
2025-07-1881.3PUT500 5520TRUE1.30
2025-07-1890PUT0 0373.1TRUE00
2025-07-18100PUT0 0282.48TRUE00
2025-07-18110PUT0 0196.66TRUE00
2025-07-18120PUT0 0703.11TRUE00
2025-07-18130PUT0 0715.69TRUE00
2025-07-18140PUT0 0727.14TRUE00
2025-07-18150PUT0 0737.65TRUE00
2025-07-18160PUT0 0747.35TRUE00
2025-07-18170PUT0 0756.36TRUE00
2025-07-18180PUT0 0764.77TRUE00
2025-10-1710CALL0 0313.41TRUE00
2025-10-1720CALL0 0191.64TRUE00
2025-10-1730CALL0 0276.95TRUE00
2025-10-1740CALL0 0317.69TRUE00
2025-10-1750CALL0 0344.55TRUE00
2025-10-1760CALL0 102364.45TRUE00
2025-10-1770.85CALL0 544401.7TRUE00
2025-10-1780.8CALL0 78393.05FALSE00
2025-10-1790.45CALL0 81403.97FALSE00
2025-10-17100.35CALL0 409480.39FALSE00
2025-10-17110CALL0 1421.71FALSE00
2025-10-17120CALL0 4429.1FALSE00
2025-10-17130CALL0 112435.75FALSE00
2025-10-17140CALL0 2441.79FALSE00
2025-10-17150.19CALL0 300447.32FALSE00
2025-10-17160CALL0 0452.41FALSE00
2025-10-17170CALL0 0457.13FALSE00
2025-10-17180CALL0 2044461.52FALSE00
2025-10-1710PUT0 00FALSE00
2025-10-1720PUT0 00FALSE00
2025-10-1730PUT0 00FALSE00
2025-10-1740PUT0 00FALSE00
2025-10-1750PUT0 3000FALSE00
2025-10-1760.4PUT0 161859.74FALSE00
2025-10-1771.05PUT0 467354.31FALSE00
2025-10-1781PUT0 112276.9TRUE00
2025-10-1791.65PUT0 51217.26TRUE00
2025-10-17100PUT0 2165.53TRUE00
2025-10-17110PUT0 9113.79TRUE00
2025-10-17120PUT0 0410.17TRUE00
2025-10-17130PUT0 0417.97TRUE00
2025-10-17140PUT0 0425.11TRUE00
2025-10-17150PUT0 0431.71TRUE00
2025-10-17160PUT0 0437.84TRUE00
2025-10-17170PUT0 0443.57TRUE00
2025-10-17180PUT0 0448.94TRUE00
2026-01-1610CALL0 3240.5TRUE00
2026-01-1620CALL0 2145.58TRUE00
2026-01-1630CALL0 152212.78TRUE00
2026-01-1640CALL0 219380.14TRUE00
2026-01-1650CALL0 172483.24TRUE00
2026-01-1661.23CALL0 2280.84TRUE00
2026-01-1671.48CALL0 1055556.73TRUE00
2026-01-1681.65CALL0 336303.03FALSE00
2026-01-1691.2CALL0 40311.49FALSE00
2026-01-16101.04CALL0 536988.06FALSE00
2026-01-16110CALL0 0325.25FALSE00
2026-01-16120CALL0 11167.8FALSE00
2026-01-16130CALL0 0336.13FALSE00
2026-01-16140CALL0 0340.81FALSE00
2026-01-16150.1CALL0 433375.49FALSE00
2026-01-16160CALL0 0349.04FALSE00
2026-01-16170CALL0 2352.69FALSE00
2026-01-1610PUT0 410FALSE00
2026-01-1620PUT0 720FALSE00
2026-01-1630PUT0 450FALSE00
2026-01-1640PUT0 914158.15FALSE00
2026-01-1650.35PUT0 21320FALSE00
2026-01-1660PUT0 50373.8FALSE00
2026-01-1670PUT0 28277.65FALSE00
2026-01-1681.55PUT0 101217.2TRUE00
2026-01-1690PUT0 0170.83TRUE00
2026-01-16100PUT0 0130.81TRUE00
2026-01-16110PUT0 091.08TRUE00
2026-01-16120PUT0 0323.08TRUE00
2026-01-16130PUT0 0329.52TRUE00
2026-01-16140PUT0 0335.43TRUE00
2026-01-16150PUT0 0340.9TRUE00
2026-01-16160PUT0 0346.02TRUE00
2026-01-16170PUT0 0350.82TRUE00

Latest LOGC Trades:

Date Shares Price
Jun 13, 2022 7:47 PM EST200$0.4539
Jun 13, 2022 7:50 PM EST100$0.4499
Jun 13, 2022 7:50 PM EST200$0.4499
Jun 13, 2022 7:50 PM EST100$0.4499
Jun 13, 2022 7:50 PM EST100$0.4477

LogicBio Therapeutics, Inc (LOGC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2019-11-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000019015732/0000000000-19-015732-index.htm
2020-05-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000020004765/0000000000-20-004765-index.htm
2020-06-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000020005085/0000000000-20-005085-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026987/0000899243-18-026987-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026988/0000899243-18-026988-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026992/0000899243-18-026992-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026993/0000899243-18-026993-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026994/0000899243-18-026994-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026998/0000899243-18-026998-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026999/0000899243-18-026999-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027001/0000899243-18-027001-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027002/0000899243-18-027002-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027005/0000899243-18-027005-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027007/0000899243-18-027007-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027010/0000899243-18-027010-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027011/0000899243-18-027011-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027012/0000899243-18-027012-index.htm
2018-10-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027096/0000899243-18-027096-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027210/0000899243-18-027210-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027211/0000899243-18-027211-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027212/0000899243-18-027212-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027213/0000899243-18-027213-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027217/0000899243-18-027217-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027218/0000899243-18-027218-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027219/0000899243-18-027219-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027222/0000899243-18-027222-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027225/0000899243-18-027225-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027226/0000899243-18-027226-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027227/0000899243-18-027227-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027229/0000899243-18-027229-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027231/0000899243-18-027231-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027375/0000899243-18-027375-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027378/0000899243-18-027378-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027379/0000899243-18-027379-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027380/0000899243-18-027380-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027381/0000899243-18-027381-index.htm
2018-10-253/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027415/0000899243-18-027415-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2019-02-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319004572/0000899243-19-004572-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319004574/0000899243-19-004574-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2019-05-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000090266419002407/0000902664-19-002407-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000090266420000940/0000902664-20-000940-index.htm
2018-11-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000094787118000868/0000947871-18-000868-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000780/0000947871-20-000780-index.htm
2018-10-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518295666/0001193125-18-295666-index.htm
2018-10-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518297645/0001193125-18-297645-index.htm
2018-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312518300264/0001193125-18-300264-index.htm
2018-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312518300269/0001193125-18-300269-index.htm
2018-10-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518301103/0001193125-18-301103-index.htm
2018-10-178-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518301114/0001193125-18-301114-index.htm
2018-10-19POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518302176/0001193125-18-302176-index.htm
2018-10-22424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518303289/0001193125-18-303289-index.htm
2018-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518310599/0001193125-18-310599-index.htm
2018-11-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000119312518317070/0001193125-18-317070-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518340421/0001193125-18-340421-index.htm
2018-12-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518341169/0001193125-18-341169-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518354565/0001193125-18-354565-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519036007/0001193125-19-036007-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519036039/0001193125-19-036039-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519057916/0001193125-19-057916-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519093656/0001193125-19-093656-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000119312519094593/0001193125-19-094593-index.htm
2019-04-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519095708/0001193125-19-095708-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519105205/0001193125-19-105205-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519110925/0001193125-19-110925-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519125202/0001193125-19-125202-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312519125235/0001193125-19-125235-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519146010/0001193125-19-146010-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312519146603/0001193125-19-146603-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519180202/0001193125-19-180202-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519184362/0001193125-19-184362-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519188256/0001193125-19-188256-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519219514/0001193125-19-219514-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312519219972/0001193125-19-219972-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519288366/0001193125-19-288366-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519289315/0001193125-19-289315-index.htm
2019-11-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312519293465/0001193125-19-293465-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312519297651/0001193125-19-297651-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520005091/0001193125-20-005091-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520029995/0001193125-20-029995-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520074884/0001193125-20-074884-index.htm
2020-03-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1664106/000119312520075995/0001193125-20-075995-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520080815/0001193125-20-080815-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1664106/000119312520124363/0001193125-20-124363-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312520124383/0001193125-20-124383-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520139024/0001193125-20-139024-index.htm
2020-06-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312520161349/0001193125-20-161349-index.htm
2020-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312520162213/0001193125-20-162213-index.htm
2020-06-0510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000119312520162226/0001193125-20-162226-index.htm
2020-06-0510-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520162248/0001193125-20-162248-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520171447/0001193125-20-171447-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520214074/0001193125-20-214074-index.htm
2020-09-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000119312520257792/0001193125-20-257792-index.htm
2020-09-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520259681/0001193125-20-259681-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520259688/0001193125-20-259688-index.htm
2020-10-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520262477/0001193125-20-262477-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520263197/0001193125-20-263197-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520284838/0001193125-20-284838-index.htm
2019-11-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119057546/0001209191-19-057546-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119060530/0001209191-19-060530-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061660/0001209191-19-061660-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061662/0001209191-19-061662-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061663/0001209191-19-061663-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061664/0001209191-19-061664-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061665/0001209191-19-061665-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061666/0001209191-19-061666-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061671/0001209191-19-061671-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009447/0001209191-20-009447-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009448/0001209191-20-009448-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009449/0001209191-20-009449-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009450/0001209191-20-009450-index.htm
2020-03-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120020340/0001209191-20-020340-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120020355/0001209191-20-020355-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024991/0001209191-20-024991-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024992/0001209191-20-024992-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024993/0001209191-20-024993-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038659/0001209191-20-038659-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038661/0001209191-20-038661-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038662/0001209191-20-038662-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038664/0001209191-20-038664-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038665/0001209191-20-038665-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038667/0001209191-20-038667-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038668/0001209191-20-038668-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000121390020003725/0001213900-20-003725-index.htm
2020-02-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000121390020004495/0001213900-20-004495-index.htm
2018-10-18CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1664106/000135445718000419/0001354457-18-000419-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459019042912/0001564590-19-042912-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000156459020011170/0001564590-20-011170-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459020024240/0001564590-20-024240-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459020038622/0001564590-20-038622-index.htm
2018-10-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1664106/999999999518002661/9999999995-18-002661-index.htm
2019-11-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1664106/999999999519002659/9999999995-19-002659-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1664106/999999999718008680/9999999997-18-008680-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1664106/999999999719003401/9999999997-19-003401-index.htm

LogicBio Therapeutics, Inc (LOGC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of LogicBio Therapeutics, Inc (LOGC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1369%
Institutional Ownership: 5300%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-10-23Tomer KarivDirectorBuy207,151.0010.002,071,510.001,574,564.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23Tomer KarivDirectorBuy112,000.0010.001,120,000.001,686,564.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23Sofia IoannidouDirectorBuy420,000.0010.004,200,000.001,787,413.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-23Tomer KarivDirectorBuy100,849.0010.001,008,490.001,787,413.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2020-09-28Bioscience plc Arix10% Share HolderSell273,584.007.542,061,865.822,381,436.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-25Bioscience plc Arix10% Share HolderSell174,219.007.081,232,947.862,655,020.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-24Bioscience plc Arix10% Share HolderSell38,514.007.63293,823.312,829,239.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-10-01Erez ChimovitsDirectorBuy296,296.006.001,777,776.00296,296.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy296,296.006.001,777,776.00296,296.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23Bioscience plc Arix10% Share HolderBuy700,000.0010.007,000,000.002,979,023.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2018-10-23Daniel P O'ConnellDirectorBuy700,000.0010.007,000,000.002,979,023.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-23Erez ChimovitsDirectorBuy490,000.0010.004,900,000.003,487,760.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2020-10-01Erez ChimovitsDirectorBuy545,974.006.003,275,844.003,524,997.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy545,974.006.003,275,844.003,524,997.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-01Erez ChimovitsDirectorBuy639,212.006.003,835,272.004,126,972.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy639,212.006.003,835,272.004,126,972.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23ORBIMED ADVISORS LLCDirectorBuy490,000.0010.004,900,000.005,766,783.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-23ORBIMED ADVISORS LLCDirectorBuy700,000.0010.007,000,000.006,466,783.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2019-08-27Thomas WiltonChief Business OfficerBuy75,000.000.7354,750.0075,000.00https://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm